With the ongoing shortage of livers available for transplantation, attention has turned to cell-based approaches to support liver function and enable liver regeneration. However, hepatocyte transplantation is beset with problems and a clinically adoptable strategy is lacking. How can a plentiful supply of hepatocyte-like cells with long-term proliferation be generated?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
Stem Cell Research & Therapy Open Access 03 September 2020
-
Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
Stem Cell Research & Therapy Open Access 08 July 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Bird, T. G. et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc. Natl Acad. Sci. USA 110, 6542–6547 (2013).
Yusa, K. et al. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478, 391–394 (2011).
Zhu, S. et al. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature http://dx.doi.org/10.1038/nature13020.
Basma, H. et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 136, 990–999 (2009).
Woo, D. H. et al. Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice. Gastroenterology 142, 602–611 (2012).
Liu, H., Kim, Y., Sharkis, S., Marchionni, L. & Jang, Y. Y. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci. Transl. Med. 3, 82ra39 (2011).
Huang, P. et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 475, 386–389 (2011).
Huang, P. et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 14, 370–384 (2014).
Du, Y. et al. Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell 14, 394–403 (2014).
Boulter, L. et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat. Med. 18, 572–579 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Forbes, S., Alison, M. Knocking on the door to successful hepatocyte transplantation. Nat Rev Gastroenterol Hepatol 11, 277–278 (2014). https://doi.org/10.1038/nrgastro.2014.44
Published:
Issue date:
DOI: https://doi.org/10.1038/nrgastro.2014.44
This article is cited by
-
Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
Stem Cell Research & Therapy (2020)
-
Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
Stem Cell Research & Therapy (2019)